Log in to save to my catalogue

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7757533

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

About this item

Full title

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

Publisher

United States: Mary Ann Liebert, Inc

Journal title

Journal of neurotrauma, 2021-01, Vol.38 (1), p.1-43

Language

English

Formats

Publication information

Publisher

United States: Mary Ann Liebert, Inc

More information

Scope and Contents

Contents

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus attacks multiple organs of coronavirus disease 2019 (COVID-19) patients, including the brain. There are worldwide descriptions of neurological deficits in COVID-19 patients. Central nervous system (CNS) symptoms can be present early in the course of the disease. As many as 55% o...

Alternative Titles

Full title

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7757533

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7757533

Other Identifiers

ISSN

0897-7151

E-ISSN

1557-9042

DOI

10.1089/neu.2020.7332

How to access this item